The opioid crisis has grown to affect pregnant women and infants across the United States,
as evidenced by rising rates of opioid use disorder among pregnant women and neonatal …

Abstract The United States opioid epidemic is a nationwide public health crisis. Initially
driven by increased consumption and availability of pharmaceutical opioids, an increasing …

Neonatal abstinence syndrome (NAS) is a result of the sudden discontinuation of fetal
exposure to substances that were used or abused by the mother during pregnancy …

Maternal use of certain drugs during pregnancy can result in transient neonatal signs
consistent with withdrawal or acute toxicity or cause sustained signs consistent with a lasting …

BACKGROUND AND OBJECTIVES: Although opioid pain relievers are commonly
prescribed in pregnancy, their association with neonatal outcomes is poorly described. Our …

In April 2016, the Eunice Kennedy Shriver National Institute of Child Health and Human
Development invited experts to a workshop to address numerous knowledge gaps and to …

Objective Detoxification followed by abstinence has shown little success in reducing illicit
opioid use. Methadone maintenance treatment (MMT) helps individuals with an opioid use …

Objectives: The prevalence of opioid use disorder (OUD) during pregnancy is increasing.
Practical recommendations will help providers treat pregnant women with OUD and reduce …

The British Association for Psychopharmacology guidelines for the treatment of substance
abuse, harmful use, addiction and comorbidity with psychiatric disorders primarily focus on …

Purpose The American Society of Addiction Medicine (ASAM) developed the National
Practice Guideline for the Treatment of Opioid Use Disorder (the Practice Guideline) to …